ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 51 | 0 | 2,280 | 1,064 | 11 |
| Gross Profit | 51 | N/A | 2,280 | 1,064 | 11 |
| Operating Expenses | 11,292 | 10,240 | 11,239 | 33,436 | 6,381 |
| Operating Income | -11,240 | -10,240 | -8,959 | -32,372 | -6,371 |
| Interest Expense | 172 | 172 | 172 | 0 | 0 |
| Other Income | -178 | -382 | -1,409 | -114 | 0 |
| Pre-tax Income | -11,590 | -10,794 | -10,540 | -32,486 | -6,371 |
| Net Income Continuous | -11,590 | -10,794 | -10,540 | -32,486 | -6,371 |
| Net Income | $-11,590 | $-10,794 | $-10,540 | $-32,486 | $-6,371 |
| EPS Basic Total Ops | -5.76 | -6.12 | -6.84 | -31.31 | -7.56 |
| EPS Basic Continuous Ops | -5.86 | -6.01 | -6.74 | -31.47 | -7.53 |
| EPS Diluted Total Ops | -5.76 | -6.12 | -6.84 | -31.31 | -7.56 |
| EPS Diluted Continuous Ops | -5.86 | -6.01 | -6.74 | -31.47 | -7.53 |
| EBITDA(a) | $-11,199 | $-10,198 | $-8,914 | $-32,331 | $-6,337 |